Sales of legal pot vapes have stabilised in key states even as the number of injuries related to the device has topped 1,000 and a growing list of jurisdictions seek bans.
Cannabis vape pens lost significant market share in the legal recreational markets of California, Colorado, Nevada and Washington between late August, when the first illness was reported, and mid-September, according to data from Seattle-based cannabis analytics firm Headset Inc.
Those declines have steadied in the past three weeks except in Colorado, where vape pens accounted for just 11% of total recreational cannabis sales as of Sept. 30, down from 19% in June.
Interestingly, sales of dried flower haven't benefited much from the decline in vape demand. In fact, flower's market share in Nevada actually fell in September, while it was more or less flat in California and Washington.
In the U.S., the National Cannabis Industry Association last week urged the federal government to take a similar regulatory approach by removing cannabis from its list of controlled substances and treating it in a manner similar to alcohol, while also making funds available to state medical authorities so they can investigate the illnesses.